Journal of International Oncology ›› 2020, Vol. 47 ›› Issue (2): 98-102.doi: 10.3760/cma.j.issn.1673-422X.2020.02.007
• Reviews • Previous Articles Next Articles
Received:
2019-10-31
Revised:
2019-12-02
Online:
2020-02-08
Published:
2020-05-27
Contact:
Nan Yang
E-mail:2011nanyang@163.com
Supported by:
Nan Yang, Zhong Yue. New research advances of long non-coding RNA in glioma[J]. Journal of International Oncology, 2020, 47(2): 98-102.
[1] | 南阳, 钟跃 . 恶性胶质瘤的分子靶向治疗[J]. 国际肿瘤学杂志, 2017,44(8):689-692. DOI: 10.3760/cma.j.issn.1673-422X.2017.09.012. |
[2] | Louis DN, Perry A, Reifenberger G , et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary[J]. Acta Neuropathol, 2016,131(6):803-820. DOI: 10.1007/s00401-016-1545-1. |
[3] | Inamura K . Major tumor suppressor and oncogenic non-coding RNAs: clinical relevance in lung cancer[J]. Cells, 2017, 6(2). pii: E12. DOI: 10.3390/cells6020012. |
[4] | Hu L, Lv QL Chen , et al. Up-regulation of long non-coding RNA AB073614 predicts a poor prognosis in patients with glioma[J]. Int J Environ Res Public Health, 2016,13(4):433. DOI: 10.3390/ijerph13040433. |
[5] | Li J, Wang YM, Song YL . Knockdown of long noncoding RNA AB073614 inhibits glioma cell proliferation and migration via affecting epithelial-mesenchymal transition[J]. Eur Rev Med Pharmacol Sci, 2016,20(19):3997-4002. |
[6] | Pervan, CL. Smad-independent TGF-β2 signaling pathways in human trabecular meshwork cells[J]. Exp Eye Res, 2017,158:137-145. DOI: 10.1016/j.exer.2016.07.012. |
[7] | Wang ZH, Guo XQ, Zhang QS , et al. Long non-coding RNA CCAT1 promotes glioma cell proliferation via inhibiting microRNA-410[J]. Biochem Biophys Res Commun, 2016,480(4):715-720. DOI: 10.1016/j.bbrc.2016.10.047. |
[8] | Guo H, Hu G, Yang Q , et al. Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells[J]. Oncotarget, 2016,7(49):81806-81814. DOI: 10.18632/oncotarget.13242. |
[9] | Zhang H, Wei DL, Wan L , et al. Highly expressed lncRNA CCND2-AS1 promotes glioma cell proliferation through Wnt/β-catenin signaling[J]. Biochem Biophys Res Commun, 2017,482(4):1219-1225. DOI: 10.1016/j.bbrc.2016.12.016. |
[10] | Zheng J, Liu X, Wang P , et al. CRNDE promotes malignant progression of glioma by attenuating miR-384/PIWIL4/STAT3 axis[J]. Mol Ther, 2016,24(7):1199-1215. DOI: 10.1038/mt.2016.71. |
[11] | Kiang KM, Zhang XQ, Zhang GP , et al. CRNDE expression positively correlates with EGFR activation and modulates glioma cell growth[J]. Target Oncol, 2017,12(3):353-363. DOI: 10.1007/s11523-017-0488-3. |
[12] | Wang S, Hui Y, Li X , et al. Silencing of lncRNA CCDC26 restrains the growth and migration of glioma cells in vitro and in vivo via targeting miR-203[J]. Oncol Res, 2018,26(8):1143-1154. DOI: 10.3727/096504017X14965095236521. |
[13] | Chen X, Gao Y, Li D , et al. LncRNA-TP53TG1 participated in the stress response under glucose deprivation in glioma[J]. J Cell Biochem, 2017,118(12):4897-4904. DOI: 10.1002/jcb.26175. |
[14] | Zhou Y, Wang DL, Pang Q . Long noncoding RNA SPRY4-IT1 is a prognostic factor for poor overall survival and has an oncogenic role in glioma[J]. Eur Rev Med Pharmacol Sci, 2016,20(14):3035-3039. |
[15] | Zhang R, Jin H, Lou F . The long non-coding RNA TP73-AS1 interacted with miR-142 to modulate brain glioma growth through HMGB1/RAGE pathway[J]. J Cell Biochem, 2018,119(4):3007-3016. DOI: 10.1002/jcb.26021. |
[16] | Deguchi S, Katsushima K, Hatanaka A , et al. Oncogenic effects of evolutionarily conserved noncoding RNA ECONEXIN on gliomagenesis[J]. Oncogene, 2017,36(32):4629-4640. DOI: 10.1038/onc.2017.88. |
[17] | Cheng Z, Li Z, Ma K , et al. Long non-coding RNA XIST promotes glioma tumorigenicity and angiogenesis by acting as a molecular sponge of miR-429[J]. J Cancer, 2017,8(19):4106-4116. DOI: 10.7150/jca.21024. |
[18] | Lv QL, Hu L, Chen SH , et al. A long noncoding RNA ZEB1-AS1 promotes tumorigenesis and predicts poor prognosis in glioma[J]. Int J Mol Sci, 2016,17(9):1431. DOI: 10.3390/ijms17091431. |
[19] | Gao K, Ji Z, She K , et al. Long non-coding RNA ZFAS1 is an unfavourable prognostic factor and promotes glioma cell progression by activation of the Notch signaling pathway[J]. Biomed Pharmacother, 2017,87:555-560. DOI: 10.1016/j.biopha.2017.01.014. |
[20] | Hu G W, Wu L, Kuang W , et al. Knockdown of linc-OIP5 inhibits proliferation and migration of glioma cells through down-regulation of YAP-NOTCH signaling pathway[J]. Gene, 2017,610:24-31. DOI: 10.1016/j.gene.2017.02.006. |
[21] | Chen ZH, Hu HK, Zhang CR , et al. Down-regulation of long non-coding RNA FOXD3 antisense RNA 1 (FOXD3-AS1) inhibits cell proliferation, migration, and invasion in malignant glioma cells[J]. Am J Transl Res, 2016,8(10):4106-4119. |
[22] | Zhao W, Sun C, Cui Z . A long noncoding RNA UCA1 promotes proliferation and predicts poor prognosis in glioma[J]. Clin Transl Oncol, 2017,19(6):735-741. DOI: 10.1007/s12094-016-1597-7. |
[23] | Ke J, Yao Y, Zheng J , et al. Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326[J]. Oncotarget, 2015,6(26):21934-21949. DOI: 10.18632/oncotarget.4290. |
[24] |
Xu C, He T, Li Z , et al. Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells[J]. Biomed Pharmacother, 2017,95:1504-1513. DOI: 10.1016/j.biopha.2017.08.097.
doi: 10.1016/j.biopha.2017.08.097 |
[25] | Zhu Y, Zhang X, Qi L , et al. HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/AKT/mTOR signaling pathway in human gliomas[J]. Oncotarget, 2016,7(12):14429-14440. DOI: 10.18632/oncotarget.7418. |
[26] | Wu X, Wang Y, Yu T , et al. Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma[J]. Neuro Oncol, 2017,19(9):1195-1205. DOI: 10.1093/neuonc/nox017. |
[27] | Zhen L, Yun-Hui L, Hong-Yu D , et al. Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis[J]. Tumour Biol, 2016,37(1):673-683. DOI: 10.1007/s13277-015-3843-y. |
[28] | Gong W, Zheng J, Liu X , et al. Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNAlet-7e[J]. Oncotarget, 2016,7(38):62208-62223. DOI: 10.18632/oncotarget.11403. |
[29] | Xue W, Chen J, Liu X , et al. PVT1 regulates the malignant behaviors of human glioma cells by targeting miR-190a-5p and miR-488-3p[J]. Biochim Biophys Acta Mol Basis Dis, 2018,1864(5 Pt A):1783-1794. DOI: 10.1016/j.bbadis.2018.02.022. |
[30] | Liao Y, Shen L, Zhao H , et al. LncRNA CASC2 interacts with miR-181a to modulate glioma growth and resistance to TMZ through PTEN pathway[J]. J Cell Biochem, 2017,118(7):1889-1899. DOI: 10.1002/jcb.25910. |
[31] | Zhang S, Wang W, Liu G , et al. Long non-coding RNA HOTTIP promotes hypoxia-induced epithelial-mesenchymal transition of malignant glioma by regulating the miR-101/ZEB1 axis[J]. Biomed Pharmacother, 2017,95:711-720. DOI: 10.1016/j.biopha.2017.08.133. |
[32] | Han Y, Wu Z, Wu T , et al. Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling[J]. Cell Death Dis, 2016,7:e2123. DOI: 10.1038/cddis.2015.407. |
[33] | Fu Z, Luo W, Wang J , et al. Malat1 activates autophagy and promotes cell proliferation by sponging miR-101 and upregulating STMN1, RAB5A and ATG4D expression in glioma[J]. Biochem Biophys Res Commun, 2017,492(3):480-486. DOI: 10.1016/j.bbrc.2017.08.070. |
[34] | Yue H, Zhu J, Xie S , et al. MDC1-AS, an antisense long noncoding RNA, regulates cell proliferation of glioma[J]. Biomed Pharmacother, 2016,81:203-209. DOI: 10.1016/j.biopha.2016.03.002. |
[35] | Qin N, Tong GF, Sun LW , et al. Long noncoding RNA MEG3 suppresses glioma cell proliferation, migration, and invasion by acting as a competing endogenous RNA of miR-19a[J]. Oncol Res, 2017,25(9):1471-1478. DOI: 10.3727/096504017X148866-89179993. |
[36] |
Li J, An G, Zhang M , et al. Long non-coding RNA TUG1 acts as a miR-26a sponge in human glioma cells[J]. Biochem Biophys Res Commun, 2016,477(4):743-748. DOI: 10.1016/j.bbrc.2016.06.129.
doi: 10.1016/j.bbrc.2016.06.129 |
[37] | Shang C, Guo Y, Hong Y , et al. Long non-coding RNA TUSC7, a target of miR-23b, plays tumor-suppressing roles in human gliomas[J]. Front Cell Neurosci, 2016,10:235. DOI: 10.3389/fncel.2016.00235. |
[1] | Liu Pingping, He Xuefang, Zhang Yi, Yang Xu, Zhang Shanshan, Ji Yifei. Risk factors of postoperative recurrence in patients with primary brain glioma and prediction model construction [J]. Journal of International Oncology, 2024, 51(4): 193-197. |
[2] | Xiao Nan, Sun Pengfei. Research progress of oxidative stress in the sensitivity of chemoradiotherapy for gliomas [J]. Journal of International Oncology, 2022, 49(6): 357-361. |
[3] | Zhu Yishuo, Cui Yujie, Liu Qi, Li Jun, Fan Yuechao. Analysis of risk factors and prediction model establishment for early postoperative recurrence in glioma patients [J]. Journal of International Oncology, 2022, 49(2): 79-83. |
[4] | Kong Chunyu, Sun Pengfei. SLC7A11 and glioma [J]. Journal of International Oncology, 2022, 49(10): 604-607. |
[5] | Guo Shihao, Ren Yeqing, Guo Geng. Molecular mechanism of vasculogenic mimicry in brain glioma [J]. Journal of International Oncology, 2021, 48(6): 362-365. |
[6] | Wang Xianwei, Shi Meiyan, Wang Fengqin, Qi Fu, Wang Chaozhe, Zhou Fei. Roles of TSA upregulation miR-4298 targeting inhibition of PADI4 expression in inducing U251 cells apoptosis [J]. Journal of International Oncology, 2021, 48(4): 193-199. |
[7] | Sun Yanqi, Ren Yeqing, Guo Geng. Mechanism of inhibitory effect of interferon and its related signal pathway on the invasion of glioma [J]. Journal of International Oncology, 2021, 48(3): 172-175. |
[8] | Zhao Congxuan, Yu Tao. Mining and prediction of glioma-related genes [J]. Journal of International Oncology, 2020, 47(5): 293-296. |
[9] | Zhang Wen, Song Qibin, Hu Weiguo. Clinical application of multimodal magnetic resonance imaging in glioma [J]. Journal of International Oncology, 2020, 47(11): 686-690. |
[10] | Chen Liang, Qin Jun, Lei Junrong, Liu Jun, Wang Lu. miR-1254 inhibits the proliferation and invasion of glioma cells by targeting CSF-1 [J]. Journal of International Oncology, 2020, 47(10): 577-584. |
[11] | Zhang Qianhui, Zhang Yang, Su Weipeng, Zhang Song′an, Liu Pan, Zhao Huarong. Expressions of LSD1, MGMT and Ki-67 in high-grade glioma and their influences on prognosis [J]. Journal of International Oncology, 2019, 46(9): 519-525. |
[12] | Yi Lin, Qiu Shi. Anti-tumor effect and mechanisms of shikonin on gliomas [J]. Journal of International Oncology, 2019, 46(8): 489-491. |
[13] | Yu Xuejuan, An Hongwei, Sun Yamei, Jiang Zheng, Zhang Xuehai, Yang Wenjing, Zhang Wei. Expressions of MMP2, TIMP2, Ki-67 and P53 in glioma tissues and their significance [J]. Journal of International Oncology, 2019, 46(12): 718-722. |
[14] | Lu Di, Zhang Jundong, Guo Geng, Wang Xiaogang. Research progress of interferon induced glioma cell apoptosis [J]. Journal of International Oncology, 2018, 45(7): 432-435. |
[15] | Zhang Yuanyuan, Zhu Shuxia. Mechanism of microRNA-495 in glioma [J]. Journal of International Oncology, 2018, 45(6): 362-364. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||